Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00101036
What this trial is testing

Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Ended earlyNCT02638909
What this trial is testing

Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies

Who this might be right for
Colorectal AdenocarcinomaCholangiocarcinomaPancreatic Adenocarcinoma+3 more
Criterium, Inc. 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876
What this trial is testing

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Who this might be right for
MSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more
SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Not applicableLooking for participantsNCT04340986
What this trial is testing

Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaHepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 1,250
Testing effectiveness (Phase 2)Active Not RecruitingNCT04308174
What this trial is testing

Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsGallbladder CancerCholangiocarcinoma
Asan Medical Center 45
Not applicableNot Yet RecruitingNCT07556835
What this trial is testing

Outcomes After Liver and Biliary Resection at a High-Volume Center

Who this might be right for
Liver NeoplasmsHepatobiliary DiseasesCholangiocarcinoma+6 more
Azienda USL Toscana Centro 1,000
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Testing effectiveness (Phase 2)Ended earlyNCT00478140
What this trial is testing

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderMalignant Neoplasm+4 more
National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT04137289
What this trial is testing

Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Gastrointestinal NeoplasmsCholangiocarcinomaPancreatic Neoplasms
Boehringer Ingelheim 110
Testing effectiveness (Phase 2)WithdrawnNCT00020774
What this trial is testing

SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT06017297
What this trial is testing

Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma

Who this might be right for
Borderline Resectable CarcinomaBiliary Tract Cancer
Georgetown University
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableStudy completedNCT00836992
What this trial is testing

Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+8 more
Mayo Clinic 144
Early research (Phase 1)UnknownNCT05872867
What this trial is testing

Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorLung Cancer+5 more
Wellmarker Bio 54
Not applicableActive Not RecruitingNCT04510740
What this trial is testing

Liver Cancer Registry Platform

Who this might be right for
Hepatocellular Carcinoma (HCC)Cholangiocarcinoma
iOMEDICO AG 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04383210
What this trial is testing

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorPancreatic Cancer+14 more
Elevation Oncology 54
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Early research (Phase 1)Ended earlyNCT00216437
What this trial is testing

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

Who this might be right for
Cancer of Liver
James A. Haley Veterans Administration Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03937895
What this trial is testing

Allogeneic NK Cell ("SMT-NK") in Combination With Pembrolizumab in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
SMT bio Co., Ltd. 40
Next Page